Tower Research Capital LLC (Trc) Brickell Biotech, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.07 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
N/A
-254 Reduced 2.42%
10,224 $17,000
Q2 2023

Aug 14, 2023
SELL
N/A
-9 Reduced 0.09%
10,478 $18,000
Q1 2023

May 09, 2023
BUY
N/A
4,202 Added 66.86%
10,487 $7,000
Q4 2022

Feb 10, 2023
BUY
$1.71 - $2.08 $5,001 - $6,084
2,925 Added 87.05%
6,285 $9,000
Q3 2022

Nov 10, 2022
BUY
$1.72 - $4.41 $5,779 - $14,817
3,360 New
3,360 $6,000

Others Institutions Holding BBI

# of Institutions
2
Shares Held
65K
Call Options Held
0
Put Options Held
0
View Full List

About Brickell Biotech, Inc.

BBI Quotes by TradingView
  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email